Dark

TBPH
Theravance Biopharma, Inc.
stock NASDAQ

At Close

Mar 11, 2026 3:59:58 PM EDT

13.81USD-1.532%(-0.22)519,820

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-14.03)0

After-hours

Mar 10, 2026 4:00:30 PM EDT

14.03USD-0.142%(-0.02)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

699.79M

CEO

Rick Winningham

Headquarters

George Town, Grand Cayman, Cayman Islands

Industry

Biotechnology

Last Earnings

Mar 11, 2026

CORT CPIX COLL XLV

TBPH Stats

Avg. Vol. 10 Day

1,361,426

Avg. Vol. 30 Day

730,684

Employees

340

Market Cap

699,786,272

Shares Out.

50,672,431

On/Off Exchange

63%/37%

6 Month Beta

0.99

1 Year Beta

0.55

2 Year Beta

0.57

3 Year Beta

0.58

52 Week Low

7.90

52 Week High

21.03

SMA50

18.72

SMA200

15.02

1 Week

+1.06%

1 Month

-29.22%

3 Month

-21.89%

6 Month

+0.80%

1 Year

+48.65%

2 Year

+61.14%

5 Year

-33.83%

Profile

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

TBPH Stock Summary

Theravance Biopharma, Inc. (NASDAQ:TBPH) stock price today is $13.81, and today's volume is 519,820. TBPH is down -1.532% today. The 30 day average volume is 730,684. TBPH market cap is 699.79M with 50,672,431 shares outstanding.